首页> 美国卫生研究院文献>Arthritis Research >Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

【2h】

Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

机译：风湿性疾病患者接受长期非大剂量类固醇的肺炎性肺囊炎-使用甲氧苄啶-磺胺甲恶唑进行一级预防的临床意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectivesTo investigate the incidence of pneumocystis pneumonia (PCP) and its risk factors in patients with rheumatic disease receiving non-high-dose steroid treatment, along with the risks and benefits of PCP prophylaxis.

机译：目的探讨风湿病患者接受非高剂量类固醇治疗后肺气肿性肺炎（PCP）的发生率及其危险因素，以及预防PCP的风险和益处。

著录项

期刊名称 Arthritis Research
作者
Jun Won Park; Jeffrey R. Curtis; Min Jung Kim; Hajeong Lee; Yeong Wook Song; Eun Bong Lee;
展开▼
作者单位

展开▼
年(卷),期 2019(21),-1
年度 2019
页码 207
总页数 10
原文格式 PDF
正文语种
中图分类外科学;
关键词
Pneumocystis pneumonia Glucocorticoids Trimethoprim–sulfamethoxazole Prophylaxis;

机译：肺孢子虫肺炎;糖皮质激素;甲氧苄氨嘧啶-磺胺甲基异恶唑;预防;

相似文献

外文文献
中文文献
专利

1. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole [J] . Jun Won Park, Jeffrey R. Curtis, Min Jung Kim, Arthritis research & therapy. . 2019,第1期

机译：风湿性疾病患者接受长期，非大剂量类固醇的肺囊虫性肺炎—甲氧苄啶-磺胺甲恶唑一级预防的临床意义
2. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids [J] . Park Jun Won, Curtis Jeffrey R., Moon Jinyoung, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第5期

机译：Trimethoplim-磺胺甲恶唑对肺炎肺炎肺炎肺炎肺炎肺炎患者暴露于延长高剂量糖皮质激素的预防作用
3. Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial [J] . Abe Yoshiyuki, Fujibayashi Kazutoshi, Nishizaki Yuji, Acta medica Okayama . 2019,第1期

机译：常规剂量与半剂量磺胺甲恶唑-甲氧苄啶预防系统性风湿病患者肺囊虫性肺炎：一项非盲，随机对照试验
4. Clinical effectiveness of low-power laser radiation and functioning of hemosalivatory barrier in patients with rheumatic diseases [C] . Nathaly D. Gladkova, Institute of Applied Physics, Nizhny Novgorod, Effects of Low-Power Light on Biological Systems II . 1996

机译：风湿性疾病患者低功率激光辐射和止血屏障功能的临床疗效
5. Socioeconomic Status, Benzathine Penicillin Prophylaxis, and Clinical Outcomes in Patients with Rheumatic Heart Disease [D] . ?Yilgwan, Christopher Sabo 2020

机译：社会经济地位，苯甲丝青霉素预防，以及风湿性心脏病患者的临床结果
6. Extended report: Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids [O] . Jun Won Park, Jeffrey R Curtis, Jinyoung Moon, -1

机译：扩展报告：甲氧苄啶-磺胺甲恶唑对长期暴露于大剂量糖皮质激素的风湿病患者的肺囊虫性肺炎的预防作用
7. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids [O] . Jun Won Park, Jeffrey R Curtis, Jinyoung Moon, 2017

机译：Trimethokim-Sulfamethoxole对暴露于高剂量糖皮质激素的患者肺吡啶 - 磺胺嘧啶对肺炎肺炎的预防作用

Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅